DIA458.78-1.29 -0.28%
SPX6,606.76-8.52 -0.13%
IXIC22,333.96-14.79 -0.07%

Nasdaq Down 1%; Lowe's Posts Upbeat Earnings

Benzinga·08/20/2025 16:51:47
Listen to the news

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 200 points on Wednesday.

The Dow traded down 0.07% to 44,891.07 while the NASDAQ fell 1% to 21,101.73. The S&P 500 also fell, dropping, 0.47% to 6,381.22.

Check This Out: Top 2 Health Care Stocks That May Fall Off A Cliff In August

Leading and Lagging Sectors

Consumer staples shares jumped by 1.1% on Wednesday.

In trading on Wednesday, information technology stocks fell by 1.8%.

Top Headline

Lowe's Companies, Inc. (NYSE:LOW) reported better-than-expected earnings for the second quarter.

Adjusted diluted EPS rose 5.6% to $4.33 from $4.10, topping analyst estimates of $4.24. Quarterly sales reached $23.96 billion, compared with $23.59 billion a year earlier, and came in slightly above Wall Street's estimate of $23.96 billion. Comparable sales increased 1.1%.

Lowe's updated its fiscal 2025 guidance to reflect the ADG acquisition. It now expects total sales of $84.5 billion to $85.5 billion, raised from $83.5 billion to $84.5 billion, and ahead of analyst estimates of $84.28 billion.

Equities Trading UP
           

  • NovaBay Pharmaceuticals, Inc. (NYSE:NBY) shares shot up 68% to $1.0101 after the company announced it entered into a $6 million securities purchase agreement with a private investor.
  • Shares of Shineco, Inc. (NASDAQ:SISI) got a boost, surging 30% to $6.42 after the company unveiled its on-chain cell asset tokenization platform.
  • Guess?, Inc. (NYSE:GES) shares were also up, gaining 26% to $16.76 amid the announcement that the company will go private in a $1.4 billion deal with Authentic Brands.

Equities Trading DOWN

  • enVVeno Medical Corporation (NASDAQ:NVNO) shares dropped 72% to $1.19 after the company announced the FDA has not approved its VenoValve PMA submission.
  • Shares of Calidi Biotherapeutics, Inc. (NYSE:CLDI) were down 43% to $1.72. Calidi Biotherapeutics announced the pricing of $6 million underwritten public offering.
  • James Hardie Industries plc (NYSE:JHX) was down, falling 35% to $18.59 following worse-than-expected quarterly financial results.

Commodities

In commodity news, oil traded up 1.2% to $63.10 while gold traded up 0.8% at $3,384.80.

Silver traded up 1.2% to $37.770 on Wednesday, while copper rose 0.3% to $4.4340.

Euro zone

European shares were mixed today. The eurozone's STOXX 600 rose 0.27%, while Spain's IBEX 35 Index fell 0.08%. London's FTSE 100 rose 0.87%, Germany's DAX 40 fell 0.50% and France's CAC 40 rose 0.16% during the session.

Asia Pacific Markets

Asian markets closed mixed on Wednesday, with Japan's Nikkei 225 falling 1.51%, Hong Kong's Hang Seng gaining 0.17%, China's Shanghai Composite surging 1.04% and India's BSE Sensex gaining 0.26%.

Economics

The volume of mortgage applications in the U.S. fell by 1.4% from the previous week in the second week of August.

Now Read This:

Photo via Shutterstock

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.